{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:29:42Z","timestamp":1789010982136,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T00:00:00Z","timestamp":1726272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T00:00:00Z","timestamp":1726272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300015"],"award-info":[{"award-number":["82300015"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sichuan Science and Technology Program","award":["2024NSFSC1555"],"award-info":[{"award-number":["2024NSFSC1555"]}]},{"name":"Sichuan Science and Technology Program","award":["2024NSFSC1942"],"award-info":[{"award-number":["2024NSFSC1942"]}]},{"name":"Sichuan Science and Technology Program","award":["2024YFFK0350"],"award-info":[{"award-number":["2024YFFK0350"]}]},{"name":"Sichuan Science and Technology Program","award":["2022YFS0235"],"award-info":[{"award-number":["2022YFS0235"]}]},{"name":"Sichuan Science and Technology Program","award":["2023NSFSC1699"],"award-info":[{"award-number":["2023NSFSC1699"]}]},{"name":"Sichuan Science and Technology Program","award":["2023YFS0222"],"award-info":[{"award-number":["2023YFS0222"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-024-03506-y","type":"journal-article","created":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T03:39:55Z","timestamp":1726285195000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Isolate distribution and antifungal susceptibility of Saccharomyces cerevisiae in the national regional medical center of Southwest China for women and children during 2018\u20132023"],"prefix":"10.1186","volume":"24","author":[{"given":"Ziyi","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaji","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenglin","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linghan","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongmei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,14]]},"reference":[{"key":"3506_CR1","doi-asserted-by":"crossref","unstructured":"Anoop V, Rotaru S, Shwed PS, Tayabali AF, Arvanitakis G. Review of current methods for characterizing virulence and pathogenicity potential of industrial Saccharomyces cerevisiae strains towards humans. FEMS Yeast Res. 2015;15(6).","DOI":"10.1093\/femsyr\/fov057"},{"issue":"10","key":"3506_CR2","doi-asserted-by":"publisher","first-page":"R381","DOI":"10.1016\/j.cub.2019.04.025","volume":"29","author":"J Steensels","year":"2019","unstructured":"Steensels J, Gallone B, Voordeckers K, Verstrepen KJ. Domestication of Industrial Microbes. Curr Biol. 2019;29(10):R381\u201393.","journal-title":"Curr Biol"},{"key":"3506_CR3","doi-asserted-by":"publisher","first-page":"103333","DOI":"10.1016\/j.fgb.2020.103333","volume":"137","author":"S Sen","year":"2020","unstructured":"Sen S, Mansell TJ. Yeasts as probiotics: mechanisms, outcomes, and future potential. Fungal Genet Biol. 2020;137:103333.","journal-title":"Fungal Genet Biol"},{"key":"3506_CR4","first-page":"1522","volume":"6","author":"R P\u00e9rez-Torrado","year":"2015","unstructured":"P\u00e9rez-Torrado R, Querol A. Opportunistic strains of Saccharomyces cerevisiae: a potential risk sold in Food products. Front Microbiol. 2015;6:1522.","journal-title":"Front Microbiol"},{"issue":"11","key":"3506_CR5","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1086\/497832","volume":"41","author":"A Enache-Angoulvant","year":"2005","unstructured":"Enache-Angoulvant A, Hennequin C. Invasive Saccharomyces infection: a comprehensive review. Clin Infect Dis. 2005;41(11):1559\u201368.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"3506_CR6","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1128\/jcm.27.7.1689-1691.1989","volume":"27","author":"OW Tawfik","year":"1989","unstructured":"Tawfik OW, Papasian CJ, Dixon AY, Potter LM. Saccharomyces cerevisiae pneumonia in a patient with acquired immune deficiency syndrome. J Clin Microbiol. 1989;27(7):1689\u201391.","journal-title":"J Clin Microbiol"},{"issue":"6","key":"3506_CR7","first-page":"576","volume":"81","author":"M Benhadj","year":"2024","unstructured":"Benhadj M, Menasria T, Ranque S. MALDI-TOF mass spectrometry identification and antifungal susceptibility testing of yeasts causing vulvovaginal candidiasis (VVC) in Tebessa (Northeastern Algeria). Ann Biol Clin (Paris). 2024;81(6):576\u201384.","journal-title":"Ann Biol Clin (Paris)"},{"key":"3506_CR8","doi-asserted-by":"crossref","unstructured":"Menu E, Filori Q, Dufour J-C, Ranque S, L\u2019Ollivier C. A repertoire of the Less Common Clinical yeasts. J Fungi (Basel). 2023;9(11).","DOI":"10.3390\/jof9111099"},{"key":"3506_CR9","doi-asserted-by":"crossref","unstructured":"G\u00f3rzy\u0144ska A, Kondracka K, Korzeniowska-Kowal A, Nawrot U. Antifungal susceptibility of Saccharomyces cerevisiae isolated from clinical specimens. Pathogens. 2024;13(3).","DOI":"10.3390\/pathogens13030248"},{"issue":"Suppl2","key":"3506_CR10","doi-asserted-by":"publisher","first-page":"S162","DOI":"10.1093\/cid\/ciab1057","volume":"74","author":"P Nyirjesy","year":"2022","unstructured":"Nyirjesy P, Brookhart C, Lazenby G, Schwebke J, Sobel JD. Vulvovaginal candidiasis: a review of the evidence for the 2021 Centers for Disease Control and Prevention of Sexually Transmitted Infections Treatment Guidelines. Clin Infect Dis. 2022;74(Suppl2):S162\u20138.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"3506_CR11","first-page":"578","volume":"40","author":"Chinese Thoracic Society","year":"2017","unstructured":"Chinese Thoracic Society. Chinese expert consensus on pathogen detection in bronchoalveolar lavage for pulmonary infectious diseases (2017 edition). Chin J Tuberc Respirat Dis. 2017;40(8):578\u201383.","journal-title":"Chin J Tuberc Respirat Dis"},{"issue":"1","key":"3506_CR12","doi-asserted-by":"publisher","first-page":"10435","DOI":"10.1038\/s41598-023-36857-z","volume":"13","author":"M Morard","year":"2023","unstructured":"Morard M, P\u00e9rez-Trav\u00e9s L, Perpi\u00f1\u00e1 C, Lair\u00f3n-Peris M, Collado MC, P\u00e9rez-Torrado R, et al. Comparative genomics of infective Saccharomyces cerevisiae strains reveals their food origin. Sci Rep. 2023;13(1):10435.","journal-title":"Sci Rep"},{"key":"3506_CR13","doi-asserted-by":"crossref","unstructured":"Ramos LS, Mokus L, Frota HF, Santos MV, Oliveira SSC, Oliveira MME et al. SARS-CoV-2 Post-infection and Sepsis by Saccharomyces cerevisiae: a fatal case report-focus on Fungal susceptibility and potential virulence attributes. Trop Med Infect Dis. 2023;8(2).","DOI":"10.3390\/tropicalmed8020099"},{"issue":"5","key":"3506_CR14","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/jac\/dkz568","volume":"75","author":"AM Borman","year":"2020","unstructured":"Borman AM, Muller J, Walsh-Quantick J, Szekely A, Patterson Z, Palmer MD, et al. MIC distributions for amphotericin B, fluconazole, itraconazole, voriconazole, flucytosine and anidulafungin and 35 uncommon pathogenic yeast species from the UK determined using the CLSI broth microdilution method. J Antimicrob Chemother. 2020;75(5):1194\u2013205.","journal-title":"J Antimicrob Chemother"},{"key":"3506_CR15","doi-asserted-by":"crossref","unstructured":"Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I et al. Sexually transmitted infections Treatment guidelines, 2021. MMWR Recomm Rep. 2021;70(4).","DOI":"10.15585\/mmwr.rr7004a1"},{"issue":"11","key":"3506_CR16","doi-asserted-by":"publisher","first-page":"e339","DOI":"10.1016\/S1473-3099(18)30103-8","volume":"18","author":"DW Denning","year":"2018","unstructured":"Denning DW, Kneale M, Sobel JD, Rautemaa-Richardson R. Global burden of recurrent vulvovaginal candidiasis: a systematic review. Lancet Infect Dis. 2018;18(11):e339\u201347.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"3506_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2165\/00128071-200304010-00005","volume":"4","author":"MJM Darkes","year":"2003","unstructured":"Darkes MJM, Scott LJ, Goa KL. Terbinafine: a review of its use in onychomycosis in adults. Am J Clin Dermatol. 2003;4(1):39\u201365.","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"3506_CR18","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1080\/14756366.2022.2050224","volume":"37","author":"M Szyma\u0144ski","year":"2022","unstructured":"Szyma\u0144ski M, Chmielewska S, Czy\u017cewska U, Malinowska M, Tylicki A. Echinocandins - structure, mechanism of action and use in antifungal therapy. J Enzyme Inhib Med Chem. 2022;37(1):876\u201394.","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"6","key":"3506_CR19","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.anaerobe.2011.04.008","volume":"17","author":"V Papaemmanouil","year":"2011","unstructured":"Papaemmanouil V, Georgogiannis N, Plega M, Lalaki J, Lydakis D, Dimitriou M, et al. Prevalence and susceptibility of Saccharomyces cerevisiae causing vaginitis in Greek women. Anaerobe. 2011;17(6):298\u20139.","journal-title":"Anaerobe"},{"issue":"3","key":"3506_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s11046-011-9414-x","volume":"172","author":"MJ Echeverr\u00eda-Irigoyen","year":"2011","unstructured":"Echeverr\u00eda-Irigoyen MJ, Eraso E, Cano J, Gom\u00e1riz M, Guarro J, Quind\u00f3s G. Saccharomyces cerevisiae vaginitis: microbiology and in vitro antifungal susceptibility. Mycopathologia. 2011;172(3):201\u20135.","journal-title":"Mycopathologia"},{"issue":"3","key":"3506_CR21","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1080\/21505594.2016.1247140","volume":"8","author":"HE Hallen-Adams","year":"2017","unstructured":"Hallen-Adams HE, Suhr MJ. Fungi in the healthy human gastrointestinal tract. Virulence. 2017;8(3):352\u20138.","journal-title":"Virulence"},{"issue":"7","key":"3506_CR22","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/S0141-0229(99)00086-1","volume":"25","author":"A Murphy","year":"1999","unstructured":"Murphy A, Kavanagh K. Emergence of Saccharomyces cerevisiae as a human pathogen: implications for biotechnology. Enzym Microb Technol. 1999;25(7):551\u20137.","journal-title":"Enzym Microb Technol"},{"issue":"12","key":"3506_CR23","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1111\/myc.13375","volume":"64","author":"E Wombwell","year":"2021","unstructured":"Wombwell E, Bransteitter B, Gillen LR. Incidence of Saccharomyces cerevisiae fungemia in hospitalised patients administered Saccharomyces boulardii probiotic. Mycoses. 2021;64(12):1521\u20136.","journal-title":"Mycoses"},{"key":"3506_CR24","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.10819964","author":"Z Yan","year":"2024","unstructured":"Yan Z. Clinical isolation of Saccharomyces cerevisiae antibiotics-sensitive phenotypes dataset in a women\u2019s and children\u2019s hospital. Zenodo. 2024. https:\/\/doi.org\/10.5281\/zenodo.10819964.","journal-title":"Zenodo"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-024-03506-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-024-03506-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-024-03506-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T20:20:06Z","timestamp":1726431606000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-024-03506-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,14]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3506"],"URL":"https:\/\/doi.org\/10.1186\/s12866-024-03506-y","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,14]]},"assertion":[{"value":"29 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The clinical experimental plan was approved by the Clinical Trial Ethics Committee of West China Second University Hospital, Sichuan University (No. 2023\u2009\u2212\u2009290). Informed consent for adult participation was waived by the Clinical Trial Ethics Committee of West China Second University Hospital, Sichuan University, according to the Chinese government \u201cMeasures for the Ethical Review of Life Science and Medical Research Involving Human Beings\u201d (Chapter III, Article 32, ). For minors, informed consent was obtained from legal guardians on behalf of the minors involved in the study. The work was carried out in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"345"}}